Therapeutic Value of Statins for Vascular Remodeling

Author(s): Hirotaka Nagashima, Hiroshi Kasanuki

Journal Name: Current Vascular Pharmacology

Volume 1 , Issue 3 , 2003

Become EABM
Become Reviewer
Call for Editor


HMG-CoA reductase inhibitors (statins) are effective lipid-lowering drugs widely used in patients with dyslipidemia at risk of cardiovascular diseases. Primary and secondary prevention studies have revealed a significant reduction of risk for cardiovascular diseases. However, recent studies have demonstrated that statins have direct vascular effects (pleiotropic effects) independent of lipid-lowering action. Vascular remodeling, defined as changes in size and / or structure of adult vasculature, not only allows physiological adaptation and healing but also underlines the pathogenesis of major cardiovascular diseases. Vascular remodeling can be inward, occlusive, and outward. Various cardiovascular diseases probably represent a terminal phenotype of such vascular remodeling. In this review, we will focus on the basic actions and clinical implications of statin therapy to each type of vascular remodeling in response to various stimuli.

Keywords: statin, vascular remodeling, cardiovascular disease, pleiotropic effect

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [273 - 279]
Pages: 7
DOI: 10.2174/1570161033476592
Price: $65

Article Metrics

PDF: 5